Gemazocine Explained

Gemazocine (R-15,497), also known as cyclogemine, is a non-selective opioid antagonist of the benzomorphan class.[1] [2] [3] It may have partial agonist properties at some of the opioid receptors, such as at the kappa receptor (as it induces dysphoric effects in humans), but seems to be generally antagonistic in its actions.[4]

Notes and References

  1. Book: Macdonald F . Dictionary of Pharmacological Agents . 22 April 2012 . 1997 . CRC Press . 978-0-412-46630-4 . 955 .
  2. Structural Studies of Substituted 6,7-Benzomorphan Compounds. I. The Absolute Configuration of (−)-2-Cyclopropylmethyl-2'-hydroxy-5-ethyl-9,9-dimethyl-6,7-benzomorphan (Gemazocine) Hydrobromide . Gelders YG, de Ranter CJ, Schenk H . Acta Crystallographica B . 1979 . 35 . 3 . 699–703 . 10.1107/S0567740879004477 . 1979AcCrB..35..699G .
  3. Verlinde C, De Ranter C . Assessment of the kappa-opioid activity of a series of 6,7-benzomorphans in the rabbit vas deferens . European Journal of Pharmacology . 153 . 1 . 83–87 . August 1988 . 2850928 . 10.1016/0014-2999(88)90590-0 .
  4. Freye E, Hartung E, Schenk GK . Bremazocine: an opiate that induces sedation and analgesia without respiratory depression . Anesthesia and Analgesia . 62 . 5 . 483–488 . May 1983 . 6301311 . 10.1213/00000539-198305000-00005 . free .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Gemazocine".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.